Caisson Interventional LLC
USPTO PatentsView assignee record - 30 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Caisson ranks #10,273 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 4 technology areas.
- #10,273
- of 49,997 US assignees by volume
- 45th percentile
- by Innovation Score (33.7/100)
- 19.0
- avg claims per patent
- -12%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10273 · US Corporation #10,273 · 30 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 30 grants
- UPPER-Q #10,273/49,997
- PHOTO-FINISH CamPlex
- CPC-NARROW A61F · 4 areas
- INNOV-THIN 33.7/100
- CLAIMS-RICH 19.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -12% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: CamPlex, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Caisson’s 33.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Caisson
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Hermes-Epitek · near 34
Hermes-Epitek · near
34 score
- Nerudia · near 34
Nerudia · near
34 score
- Tenacious Holdings · near 34
Tenacious Holdings · near
34 score
- Bridgeport Fittings · near 34
Bridgeport Fittings · near
34 score
- Caisson Interventional · this assignee 34
Caisson Interventional · this assignee
34 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Caisson's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Caisson?
Each dot is one of Caisson’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Caisson’s own 19.0 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Caisson's grants concentrate
Caisson Interventional LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2023. By volume, Caisson sits between Coorstek KK and Cellphone-Mate, Inc..
Caisson's three-year grant acceleration
Caisson Interventional LLC shows 6 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Caisson's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Coorstek KK
Coorstek KK
30 patents
- Crititech
Crititech, Inc.
30 patents
- CUB Elecparts
CUB Elecparts Inc.
30 patents
- Curexo
Curexo, Inc.
30 patents
- Camplex
CamPlex, Inc.
30 patents
- Candela
Candela Corporation
30 patents
- Carl Zeiss Multis…
Carl Zeiss MultiSEM GmbH
30 patents
- Cellphone-mate
Cellphone-Mate, Inc.
30 patents
- Caisson Intervent… ◀
Caisson Interventional LLC
30 patents
What this shows Caisson holds 30 patents at rank #10,281, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Caisson
By rank, the assignees closest to #10,281 in granted patent volume.
- Coorstek KK #10,277 · 30 patents
- Crititech, Inc. #10,278 · 30 patents
- CUB Elecparts Inc. #10,279 · 30 patents
- Curexo, Inc. #10,280 · 30 patents
- CamPlex, Inc. #10,282 · 30 patents
- Candela Corporation #10,283 · 30 patents
- Carl Zeiss MultiSEM GmbH #10,284 · 30 patents
- Cellphone-Mate, Inc. #10,285 · 30 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Caisson's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Caisson, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Caisson ranks #216 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (34 here).
Caisson's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 45th percentile higher than 45% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 6.7% |
| 2016 | 3 | 10.0% |
| 2017 | 4 | 13.3% |
| 2018 | 3 | 10.0% |
| 2019 | 4 | 13.3% |
| 2020 | 5 | 16.7% |
| 2021 | 3 | 10.0% |
| 2022 | 3 | 10.0% |
| 2023 | 1 | 3.3% |
| 2024 | 2 | 6.7% |
Which technologies does Caisson Interventional LLC patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Caisson Interventional LLC's patent record in context - here's where to go next.
- Caisson Interventional LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #10,273 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Caisson Interventional LLC against Coorstek KK, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.